Abstract
Background: Skin cutaneous melanoma (SKCM) is an aggressive malignant skin tumor. Ferroptosis is an iron-dependent cell death that may mobilize tumor-infiltrating immunity against cancer. The potential mechanism of long non-coding RNAs (lncRNAs) in ferroptosis in SKCM is not clear. In this study, the prognostic and treatment value of ferroptosis-related lncRNAs was explored in SKCM, and a prognostic model was established. Methods: We first explored the mutation state of ferroptosis-related genes in SKCM samples from The Cancer Genome Atlas database. Then, we utilized consensus clustering analysis to divide the samples into three clusters based on gene expression and evaluated their immune infiltration using gene-set enrichment analysis (GSEA) ESTIMATE and single-sample gene-set enrichment analysis (ssGSEA) algorithms. In addition, we applied univariate Cox analysis to screen prognostic lncRNAs and then validated their prognostic value by Kaplan–Meier (K-M) and transcripts per kilobase million (TPM) value analyses. Finally, we constructed an 18-ferroptosis-related lncRNA prognostic model by multivariate Cox analysis, and SKCM patients were allocated into different risk groups based on the median risk score. The prognostic value of the model was evaluated by K-M and time-dependent receiver operating characteristic (ROC) analyses. Additionally, the immunophenoscore (IPS) in different risk groups was detected. Results: The top three mutated ferroptosis genes were TP53, ACSL5, and TF. The SKCM patients in the cluster C had the highest ferroptosis-related gene expression with the richest immune infiltration. Based on the 18 prognosis-related lncRNAs, we constructed a prognostic model of SKCM patients. Patients at low risk had a better prognosis and higher IPS. Conclusion: Our findings revealed that ferroptosis-related lncRNAs were expected to become potential biomarkers and indicators of prognosis and immunotherapy treatment targets of SKCM.
Highlights
Skin cutaneous melanoma (SKCM), one of the most aggressive malignant skin tumors (Mohammadpour et al, 2019), is a complex mainly affected by environmental and genetic factors (Tucker and Goldstein, 2003), causing nearly 55,500 deaths annually (Schadendorf et al, 2018)
Based on the 18 prognosis-related long non-coding RNAs (lncRNAs), we constructed a prognostic model of SKCM patients
Our findings revealed that ferroptosis-related lncRNAs were expected to become potential biomarkers and indicators of prognosis and immunotherapy treatment targets of SKCM
Summary
Skin cutaneous melanoma (SKCM), one of the most aggressive malignant skin tumors (Mohammadpour et al, 2019), is a complex mainly affected by environmental and genetic factors (Tucker and Goldstein, 2003), causing nearly 55,500 deaths annually (Schadendorf et al, 2018). Traditional treatments have been the mainstream against advanced or metastatic melanoma in recent decades, their aims are mainly to relieve symptoms and reduce tumor burden, with little help for prolonging survival. Skin cutaneous melanoma (SKCM) is an aggressive malignant skin tumor. The potential mechanism of long non-coding RNAs (lncRNAs) in ferroptosis in SKCM is not clear. The prognostic and treatment value of ferroptosis-related lncRNAs was explored in SKCM, and a prognostic model was established
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
